Vanguard Capital Management’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$233K Buy
63,207
+1,603
+3% +$7.88K ﹤0.01% 3775
2026
Q2
$366K Buy
61,604
+55,687
+941% +$394K ﹤0.01% 3760
2026
Q1
$60.1K Buy
+5,917
New +$56K ﹤0.01% 3899

Other funds holding PAVM

Vanguard Capital Management's PAVM Position: Q3 2026 in Review

Vanguard Capital Management increased its PAVmed (PAVM) stake by 2.6% in Q3 2026, buying an estimated $7.88K and bringing the position to 63,207 shares worth $233K. The position accounts for ﹤0.01% of the portfolio, ranked #3775.

Vanguard Capital Management first reported a position in PAVM in Q1 2026 and has held it in 3 quarters since. The position peaked at $366K in Q2 2026. 24 funds tracked by Wall St. Rank hold PAVM as of Q3 2026.

  • Vanguard Capital Management held 63,207 shares of PAVmed worth $233K as of Q3 2026.
  • Vanguard Capital Management bought 1,603 PAVmed shares in Q3 2026, an estimated $7.88K.
  • PAVmed made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3775 holding.
  • Vanguard Capital Management first reported a position in PAVmed in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Capital Management's PAVmed position peaked at $366K in Q2 2026.
  • 24 funds tracked by Wall St. Rank held PAVmed as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.